Publications 2017

Publications auxquelles l’Aretasc a participé en 2017 :

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

Derks MGM, Blok EJ, Seynaeve C, Nortier JWR, Kranenbarg EM, Liefers GJ, Putter
H, Kroep JR, Rea D, Hasenburg A, Markopoulos C, Paridaens R, Smeets JBE, Dirix
LY, van de Velde CJH. Lancet Oncol. 2017 Sep;18(9):1211-1220. doi: 10.1016/S1470-
2045(17)30419-9. Epub 2017 Jul 18

Correlation betwen Oncotype DX recurrence score and classical risk factors in early
breast cancer.

Abstract 12011 .Asco Journal 2017.18.